Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
CorMedix Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $0.26 | $0.26 | $0.26 |
| Q2 2025 | 6 | $0.04 | $0.16 | $0.13 |
| Q3 2025 | 3 | $0.18 | $0.18 | $0.18 |
| Q4 2025 | 3 | $0.20 | $0.20 | $0.20 |
| Q1 2026 | 4 | $0.25 | $0.25 | $0.25 |
| Q2 2026 | 3 | $0.26 | $0.26 | $0.26 |
| Q3 2026 | 3 | $0.26 | $0.26 | $0.26 |
| Q4 2026 | 4 | $0.25 | $0.25 | $0.25 |
| Q1 2027 | 2 | $0.48 | $0.48 | $0.48 |
| Q2 2027 | 2 | $0.50 | $0.50 | $0.50 |
| Q3 2027 | 2 | $0.49 | $0.49 | $0.49 |
| Q4 2027 | 2 | $0.51 | $0.51 | $0.51 |
| Q1 2028 | 3 | $0.73 | $0.73 | $0.73 |
| Q2 2028 | 3 | $0.76 | $0.76 | $0.76 |
| Q3 2028 | 3 | $0.75 | $0.75 | $0.75 |
| Q4 2028 | 3 | $0.77 | $0.77 | $0.77 |
CorMedix Inc. Earnings Date And Information
CorMedix Inc. last posted its earnings results on Tuesday, May 6th, 2025. The company reported $0.3 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.05. The company had revenue of 39.08 M for the quarter and had revenue of 43.47 M for the year. CorMedix Inc. has generated $0 earnings per share over the last year ($-0.3 diluted earnings per share) and currently has a price-to-earnings ratio of 44.02. CorMedix Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based on prior year's report dates.
CorMedix Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2025 | Q1 2025 | $0.25 | $0.32 | 0.07 | $36.95 M | $39.08 M |
| 03/25/2025 | Q4 2024 | $0.17 | $0.22 | 0.05 | $27.28 M | $31.21 M |
| 10/30/2024 | Q3 2024 | -$0.10 | -$0.05 | 0.05 | $10.35 M | $11.46 M |
| 08/14/2024 | Q2 2024 | -$0.26 | -$0.25 | 0.01 | $1.67 M | $806.12 K |
| 05/09/2024 | Q1 2024 | -$0.27 | -$0.25 | 0.02 | $3.00 M | $0 |
| 03/12/2024 | Q4 2023 | -$0.21 | -$0.26 | -0.05 | $-333,333 | $304.11 K |
| 11/14/2023 | Q3 2023 | -$0.21 | -$0.17 | 0.04 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.22 | -$0.25 | -0.03 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$0.20 | $9.78 | 9.98 | N/A | $0 |
| 03/30/2023 | Q4 2022 | -$0.19 | -$0.19 | 0 | $2.33 K | $29.70 K |
| 11/10/2022 | Q3 2022 | -$0.23 | -$0.17 | 0.06 | N/A | $6.82 K |
| 08/11/2022 | Q2 2022 | -$0.20 | -$0.19 | 0.01 | N/A | $21.25 K |
| 05/12/2022 | Q1 2022 | -$0.23 | -$0.18 | 0.05 | $25.00 K | $7.64 K |
| 03/29/2022 | Q4 2021 | -$0.22 | -$0.21 | 0.01 | $19.00 K | $56.40 K |
| 11/09/2021 | Q3 2021 | -$0.18 | -$0.22 | -0.04 | $20.00 K | $38.09 K |
| 08/12/2021 | Q2 2021 | -$0.18 | -$0.12 | 0.06 | $43.25 K | $8.19 K |
| 05/13/2021 | Q1 2021 | -$0.18 | -$0.20 | -0.02 | $39.60 K | $88.26 K |
| 03/30/2021 | Q4 2020 | -$0.23 | -$0.19 | 0.04 | $46.25 K | $55.71 K |
| 11/05/2020 | Q3 2020 | -$0.26 | -$0.22 | 0.04 | $28.75 K | $93.02 K |
| 08/10/2020 | Q2 2020 | -$0.24 | -$0.14 | 0.1 | $117.50 K | $16.44 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CorMedix Inc. Earnings: FAQ's
CorMedix Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based offlast year's report dates.
In the previous quarter, CorMedix Inc. (:CRMD) reported $0.3 earnings per share (EPS) to beat the analysts' consensus estimate of $0.25 by $0.05.
The conference call for CorMedix Inc.'s latest earnings report can be listened to online.
The conference call transcript for CorMedix Inc.'s latest earnings report can be read online.
CorMedix Inc. (:CRMD) has a recorded annual revenue of $43.47 M.
CorMedix Inc. (:CRMD) has a recorded net income of $-17,930,020.CorMedix Inc. has generated $-0.3 earnings per share over the last four quarters.
CorMedix Inc. (:CRMD) has a price-to-earnings ratio of 44.02 and price/earnings-to-growth ratio is 0.25.